Today and Future of Age-Related Macular Degeneration

Table 1

Epidemiological Studies of Age-related Macular Degeration (early AMD and exudative AMD): distribution by age groups (%), (percentages for exudative AMD are given in parentheses).

Study/age	50–59	60–69	70–79	Over 80
Beaver Dam (USA) 4756 patients	16.7 (0.5)	25.3 (1.4)	41.7 (6.9)	48.7 (13.5)
Proyecto VER (Hispanic people in Arizona); 2780 patients	19.8 (0.1)	27.7 (0.5)	41.3 (0.8)	54.1 (4.3)
Rotterdam (Netherlands) 6411 patients	2.5 (0.1)	9.9 (0.7)	16.7 (3.2)	29.8 (11.6)
Blue Mountains (Australia) 3585 patients	2.8 (0.2)	9.2 (0.7)	20.9 (5.4)	46.6 (18.5)
Reykjavik eye study (Iceland) 1021 patients	0.3 (0.0)	1.2 (0.0)	5.3 (0.5)	25 (9.8)
Beijing eye study (China) 4376 patients	1.4 (0.1)*

*The Beijing Eye Study are not classified by age.